MannKind Corporation [NASDAQ: MNKD] slipped around -0.04 points on Tuesday, while shares priced at $3.57 at the close of the session, down -1.11%. The company report on August 9, 2022 that MannKind Corporation Reports 2022 Second Quarter Financial Results.
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Conference Call to Begin Today at 5:00 p.m. (ET).
Tyvaso DPI™ approved by the FDA in May representing the second FDA-approved product using the Technosphere® inhalation platform.
MannKind Corporation stock is now -18.31% down from its year-to-date (YTD) trading value. MNKD Stock saw the intraday high of $3.71 and lowest of $3.495 per share. The company’s 52-week high price is 5.44, which means current price is +43.37% above from all time high which was touched on 06/08/22.
Compared to the average trading volume of 4.96M shares, MNKD reached a trading volume of 5408469 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about MannKind Corporation [MNKD]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MNKD shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MNKD stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for MannKind Corporation shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on May 14, 2021. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on December 24, 2019, representing the official price target for MannKind Corporation stock. Previously, the target price had yet another raise to $3, while Cantor Fitzgerald analysts kept a Overweight rating on MNKD stock.
The Average True Range (ATR) for MannKind Corporation is set at 0.22, with the Price to Sales ratio for MNKD stock in the period of the last 12 months amounting to 14.87.
How has MNKD stock performed recently?
MannKind Corporation [MNKD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.99. With this latest performance, MNKD shares dropped by -0.28% in over the last four-week period, additionally plugging by 29.82% over the last 6 months – not to mention a drop of -24.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MNKD stock in for the last two-week period is set at 38.56, with the RSI for the last a single of trading hit 31.41, and the three-weeks RSI is set at 42.67 for MannKind Corporation [MNKD]. The present Moving Average for the last 50 days of trading for this stock 3.90, while it was recorded at 3.77 for the last single week of trading, and 3.85 for the last 200 days.
MannKind Corporation [MNKD]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and MannKind Corporation [MNKD] shares currently have an operating margin of -70.44 and a Gross Margin at +48.49. MannKind Corporation’s Net Margin is presently recorded at -107.27.
MannKind Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.90 and a Current Ratio set at 3.20.
Earnings analysis for MannKind Corporation [MNKD]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MNKD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MannKind Corporation go to 35.60%.
Insider trade positions for MannKind Corporation [MNKD]
There are presently around $422 million, or 47.60% of MNKD stock, in the hands of institutional investors. The top three institutional holders of MNKD stocks are: BLACKROCK INC. with ownership of 21,290,953, which is approximately 2.688% of the company’s market cap and around 2.60% of the total institutional ownership; VANGUARD GROUP INC, holding 12,834,402 shares of the stock with an approximate value of $45.82 million in MNKD stocks shares; and STATE STREET CORP, currently with $44.63 million in MNKD stock with ownership of nearly -14.982% of the company’s market capitalization.
Positions in MannKind Corporation stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 77 institutional holders increased their position in MannKind Corporation [NASDAQ:MNKD] by around 15,525,068 shares. Additionally, 80 investors decreased positions by around 10,937,302 shares, while 54 investors held positions by with 91,807,960 shares. The mentioned changes placed institutional holdings at 118,270,330 shares, according to the latest SEC report filing. MNKD stock had 26 new institutional investments in for a total of 2,401,998 shares, while 25 institutional investors sold positions of 2,025,656 shares during the same period.